Gene Symbol | Gene ID | Gene Info |
---|---|---|
GMEB1
|
ENSG00000162419.8 | glucocorticoid modulatory element binding protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_28996088_28996434 | GMEB1 | 969 | 0.450915 | 0.60 | 8.8e-02 | Click! |
chr1_28994750_28995041 | GMEB1 | 349 | 0.822201 | 0.57 | 1.1e-01 | Click! |
chr1_28996542_28996693 | GMEB1 | 1325 | 0.338329 | 0.44 | 2.4e-01 | Click! |
chr1_28997235_28997386 | GMEB1 | 2018 | 0.233639 | 0.40 | 2.8e-01 | Click! |
chr1_28995908_28996059 | GMEB1 | 691 | 0.590707 | 0.37 | 3.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_133022629_133022780 | 2.04 |
MUC8 |
mucin 8 |
28022 |
0.17 |
chr17_7307184_7307335 | 1.81 |
TMEM256 |
transmembrane protein 256 |
99 |
0.54 |
chr7_30189171_30189322 | 1.67 |
MTURN |
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
3733 |
0.2 |
chr19_42462862_42463013 | 1.42 |
RABAC1 |
Rab acceptor 1 (prenylated) |
129 |
0.95 |
chr1_51435489_51435732 | 1.37 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
6 |
0.98 |
chr15_66993916_66994323 | 1.36 |
SMAD6 |
SMAD family member 6 |
447 |
0.87 |
chr4_186316955_186317190 | 1.35 |
LRP2BP |
LRP2 binding protein |
19 |
0.61 |
chr16_66387387_66387538 | 1.29 |
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
13071 |
0.2 |
chr4_5035629_5036207 | 1.29 |
CYTL1 |
cytokine-like 1 |
14719 |
0.22 |
chr1_2347463_2347709 | 1.27 |
PEX10 |
peroxisomal biogenesis factor 10 |
2350 |
0.17 |
chrX_103499710_103499861 | 1.25 |
ESX1 |
ESX homeobox 1 |
171 |
0.97 |
chr14_105486313_105486772 | 1.22 |
CDCA4 |
cell division cycle associated 4 |
855 |
0.57 |
chr5_95067315_95067466 | 1.18 |
RHOBTB3 |
Rho-related BTB domain containing 3 |
511 |
0.5 |
chr22_50627182_50627333 | 1.18 |
TRABD |
TraB domain containing |
1770 |
0.17 |
chr19_50887010_50887236 | 1.15 |
POLD1 |
polymerase (DNA directed), delta 1, catalytic subunit |
473 |
0.63 |
chr19_54057887_54058079 | 1.15 |
ZNF331 |
zinc finger protein 331 |
98 |
0.94 |
chr8_60031417_60031619 | 1.13 |
RP11-25K19.1 |
|
81 |
0.73 |
chr10_13203437_13203588 | 1.13 |
MCM10 |
minichromosome maintenance complex component 10 |
42 |
0.98 |
chr1_214612290_214612850 | 1.10 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
25576 |
0.24 |
chr10_135148910_135149072 | 1.09 |
CALY |
calcyon neuron-specific vesicular protein |
1385 |
0.21 |
chr11_235854_236005 | 1.09 |
SIRT3 |
sirtuin 3 |
397 |
0.53 |
chr9_91002852_91003067 | 1.08 |
SPIN1 |
spindlin 1 |
375 |
0.9 |
chr11_45001114_45001265 | 1.08 |
TP53I11 |
tumor protein p53 inducible protein 11 |
28581 |
0.22 |
chr22_41597347_41597566 | 1.06 |
L3MBTL2 |
l(3)mbt-like 2 (Drosophila) |
3753 |
0.13 |
chr15_69453328_69453625 | 1.05 |
ENSG00000266374 |
. |
486 |
0.47 |
chr12_55362221_55362689 | 1.05 |
TESPA1 |
thymocyte expressed, positive selection associated 1 |
4883 |
0.26 |
chr1_2398045_2398196 | 1.04 |
PLCH2 |
phospholipase C, eta 2 |
778 |
0.5 |
chr2_73461101_73461297 | 1.04 |
CCT7 |
chaperonin containing TCP1, subunit 7 (eta) |
165 |
0.88 |
chr2_8621933_8622094 | 1.03 |
AC011747.7 |
|
193883 |
0.03 |
chr3_169490542_169490716 | 1.03 |
MYNN |
myoneurin |
10 |
0.95 |
chr2_106476159_106476310 | 1.02 |
AC009505.2 |
|
2601 |
0.34 |
chr3_47822493_47822880 | 1.02 |
SMARCC1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
721 |
0.64 |
chr1_66999113_66999318 | 1.02 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
60 |
0.98 |
chr17_74666601_74666752 | 1.01 |
RP11-318A15.2 |
|
1348 |
0.25 |
chr9_20683336_20683530 | 1.01 |
FOCAD |
focadhesin |
25125 |
0.17 |
chr2_113934951_113935216 | 1.01 |
AC016683.5 |
|
2146 |
0.23 |
chr11_2291942_2292148 | 1.00 |
ASCL2 |
achaete-scute family bHLH transcription factor 2 |
137 |
0.94 |
chr2_188418719_188418870 | 1.00 |
AC007319.1 |
|
82 |
0.77 |
chr1_182991634_182991787 | 1.00 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
885 |
0.61 |
chr14_100165446_100165597 | 0.99 |
CYP46A1 |
cytochrome P450, family 46, subfamily A, polypeptide 1 |
6813 |
0.21 |
chr2_173297986_173298158 | 0.99 |
AC078883.4 |
|
4741 |
0.2 |
chr5_37841386_37841537 | 0.99 |
GDNF |
glial cell derived neurotrophic factor |
1673 |
0.47 |
chr16_8738273_8738489 | 0.99 |
METTL22 |
methyltransferase like 22 |
2056 |
0.31 |
chr2_3247597_3247902 | 0.99 |
TSSC1-IT1 |
TSSC1 intronic transcript 1 (non-protein coding) |
57487 |
0.14 |
chr2_29537156_29537327 | 0.99 |
ALK |
anaplastic lymphoma receptor tyrosine kinase |
90981 |
0.08 |
chr12_124086089_124086322 | 0.98 |
DDX55 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 |
441 |
0.74 |
chr3_132137362_132137693 | 0.97 |
DNAJC13 |
DnaJ (Hsp40) homolog, subfamily C, member 13 |
1157 |
0.6 |
chr10_21808108_21808496 | 0.97 |
SKIDA1 |
SKI/DACH domain containing 1 |
1454 |
0.31 |
chr5_1137445_1137731 | 0.97 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
25438 |
0.15 |
chr14_52119548_52120014 | 0.96 |
FRMD6 |
FERM domain containing 6 |
1083 |
0.54 |
chr12_62861008_62861159 | 0.96 |
MON2 |
MON2 homolog (S. cerevisiae) |
454 |
0.83 |
chr17_47645408_47645575 | 0.95 |
RP5-1029K10.2 |
|
5935 |
0.14 |
chr1_207262773_207263064 | 0.95 |
C4BPB |
complement component 4 binding protein, beta |
31 |
0.97 |
chr1_23810120_23810354 | 0.95 |
ASAP3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
434 |
0.83 |
chr3_51720999_51721267 | 0.95 |
ENSG00000201595 |
. |
7465 |
0.15 |
chr14_91883140_91883291 | 0.95 |
CCDC88C |
coiled-coil domain containing 88C |
475 |
0.86 |
chr9_94186812_94186963 | 0.94 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
743 |
0.78 |
chr1_231173648_231173799 | 0.94 |
FAM89A |
family with sequence similarity 89, member A |
2269 |
0.26 |
chr10_73488878_73489040 | 0.94 |
C10orf105 |
chromosome 10 open reading frame 105 |
8622 |
0.22 |
chr8_91014329_91014480 | 0.93 |
DECR1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
659 |
0.75 |
chr14_89507015_89507229 | 0.93 |
FOXN3 |
forkhead box N3 |
139966 |
0.05 |
chr13_80916975_80917126 | 0.92 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
1964 |
0.43 |
chr9_78714748_78715100 | 0.92 |
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
4031 |
0.37 |
chr9_4298868_4299215 | 0.92 |
RP11-358M14.2 |
|
349 |
0.64 |
chr3_172428387_172428709 | 0.91 |
NCEH1 |
neutral cholesterol ester hydrolase 1 |
294 |
0.88 |
chr10_43916347_43916632 | 0.91 |
ENSG00000221400 |
. |
3601 |
0.19 |
chr10_130705932_130706083 | 0.91 |
MGMT |
O-6-methylguanine-DNA methyltransferase |
559441 |
0.0 |
chr22_19962677_19962998 | 0.91 |
ENSG00000265087 |
. |
11561 |
0.11 |
chr1_234508657_234508809 | 0.89 |
COA6 |
cytochrome c oxidase assembly factor 6 homolog (S. cerevisiae) |
469 |
0.44 |
chr11_44326130_44326281 | 0.89 |
ALX4 |
ALX homeobox 4 |
5511 |
0.32 |
chr5_66492437_66492594 | 0.88 |
CD180 |
CD180 molecule |
112 |
0.98 |
chr11_64534757_64535009 | 0.88 |
SF1 |
splicing factor 1 |
206 |
0.9 |
chr8_144656219_144656478 | 0.88 |
RP11-661A12.9 |
|
688 |
0.35 |
chr6_116690381_116690532 | 0.88 |
DSE |
dermatan sulfate epimerase |
554 |
0.78 |
chr2_121493910_121494153 | 0.88 |
GLI2 |
GLI family zinc finger 2 |
208 |
0.97 |
chrX_132090899_132091056 | 0.88 |
HS6ST2 |
heparan sulfate 6-O-sulfotransferase 2 |
367 |
0.92 |
chr7_123389369_123389520 | 0.88 |
RP11-390E23.6 |
|
322 |
0.48 |
chr7_72300672_72300823 | 0.88 |
SBDSP1 |
Shwachman-Bodian-Diamond syndrome pseudogene 1 |
512 |
0.66 |
chr3_47032559_47032787 | 0.87 |
NBEAL2 |
neurobeachin-like 2 |
4138 |
0.21 |
chr6_112364520_112364671 | 0.87 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
10680 |
0.21 |
chr7_140103558_140103732 | 0.87 |
RAB19 |
RAB19, member RAS oncogene family |
198 |
0.74 |
chr5_141736086_141736309 | 0.86 |
AC005592.2 |
|
3089 |
0.32 |
chr1_5831272_5831551 | 0.86 |
ENSG00000216045 |
. |
44608 |
0.17 |
chr9_92151154_92151305 | 0.86 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
38184 |
0.17 |
chr12_11859694_11859845 | 0.86 |
ETV6 |
ets variant 6 |
45666 |
0.18 |
chr15_69086514_69086665 | 0.85 |
ENSG00000265195 |
. |
7675 |
0.24 |
chr8_61896258_61896409 | 0.85 |
CLVS1 |
clavesin 1 |
73384 |
0.12 |
chr6_108495763_108495980 | 0.85 |
NR2E1 |
nuclear receptor subfamily 2, group E, member 1 |
5904 |
0.19 |
chr16_67571086_67571309 | 0.85 |
FAM65A |
family with sequence similarity 65, member A |
160 |
0.89 |
chr17_27910417_27910568 | 0.85 |
GIT1 |
G protein-coupled receptor kinase interacting ArfGAP 1 |
398 |
0.68 |
chr5_175123108_175123334 | 0.84 |
ENSG00000200648 |
. |
7680 |
0.21 |
chr12_4261638_4262044 | 0.84 |
CCND2 |
cyclin D2 |
121097 |
0.05 |
chr6_34113886_34114037 | 0.84 |
GRM4 |
glutamate receptor, metabotropic 4 |
104 |
0.98 |
chr9_137348457_137348644 | 0.83 |
RXRA |
retinoid X receptor, alpha |
50122 |
0.15 |
chr2_45879335_45879603 | 0.83 |
PRKCE |
protein kinase C, epsilon |
556 |
0.79 |
chr8_97281993_97282144 | 0.82 |
PTDSS1 |
phosphatidylserine synthase 1 |
7927 |
0.16 |
chr9_139694082_139694314 | 0.82 |
CCDC183 |
coiled-coil domain containing 183 |
3383 |
0.09 |
chr9_99382070_99382259 | 0.82 |
CDC14B |
cell division cycle 14B |
52 |
0.98 |
chr2_202899060_202899211 | 0.82 |
FZD7 |
frizzled family receptor 7 |
175 |
0.95 |
chr19_14653453_14653779 | 0.82 |
TECR |
trans-2,3-enoyl-CoA reductase |
2920 |
0.14 |
chr1_149871468_149871676 | 0.82 |
BOLA1 |
bolA family member 1 |
393 |
0.67 |
chr11_68671987_68672233 | 0.82 |
IGHMBP2 |
immunoglobulin mu binding protein 2 |
745 |
0.42 |
chr15_86337521_86337698 | 0.82 |
KLHL25 |
kelch-like family member 25 |
491 |
0.71 |
chr19_16653824_16654004 | 0.82 |
CHERP |
calcium homeostasis endoplasmic reticulum protein |
573 |
0.55 |
chr9_141105098_141105281 | 0.82 |
TUBBP5 |
tubulin, beta pseudogene 5 |
35692 |
0.19 |
chr15_33010315_33010466 | 0.81 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
185 |
0.95 |
chr11_121321949_121322124 | 0.81 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
876 |
0.57 |
chr8_145551017_145551180 | 0.81 |
DGAT1 |
diacylglycerol O-acyltransferase 1 |
525 |
0.55 |
chr2_231576785_231576968 | 0.81 |
CAB39 |
calcium binding protein 39 |
684 |
0.74 |
chr4_106124296_106124447 | 0.81 |
TET2-AS1 |
TET2 antisense RNA 1 |
25151 |
0.2 |
chr5_134369071_134369280 | 0.80 |
C5orf66 |
chromosome 5 open reading frame 66 |
205 |
0.67 |
chr12_106675992_106676143 | 0.80 |
ENSG00000238609 |
. |
700 |
0.66 |
chr11_33280144_33280348 | 0.80 |
HIPK3 |
homeodomain interacting protein kinase 3 |
369 |
0.89 |
chr17_46048605_46048756 | 0.80 |
CDK5RAP3 |
CDK5 regulatory subunit associated protein 3 |
163 |
0.9 |
chr7_99156909_99157063 | 0.80 |
ZNF655 |
zinc finger protein 655 |
501 |
0.55 |
chr1_33282419_33282585 | 0.80 |
S100PBP |
S100P binding protein |
134 |
0.93 |
chr1_31986580_31986731 | 0.79 |
ENSG00000206981 |
. |
16130 |
0.16 |
chr4_140862548_140862834 | 0.79 |
MAML3 |
mastermind-like 3 (Drosophila) |
50570 |
0.17 |
chr8_107672029_107672266 | 0.79 |
OXR1 |
oxidation resistance 1 |
2065 |
0.32 |
chr5_92916417_92916950 | 0.79 |
ENSG00000237187 |
. |
30 |
0.98 |
chr4_99578599_99578919 | 0.79 |
TSPAN5 |
tetraspanin 5 |
27 |
0.97 |
chr2_160760528_160760892 | 0.79 |
LY75 |
lymphocyte antigen 75 |
483 |
0.49 |
chr10_18948711_18948862 | 0.78 |
ARL5B |
ADP-ribosylation factor-like 5B |
452 |
0.82 |
chr2_74765906_74766137 | 0.78 |
HTRA2 |
HtrA serine peptidase 2 |
8848 |
0.07 |
chr13_74707001_74707220 | 0.78 |
KLF12 |
Kruppel-like factor 12 |
1284 |
0.63 |
chr8_20161069_20161242 | 0.78 |
LZTS1 |
leucine zipper, putative tumor suppressor 1 |
319 |
0.91 |
chr4_74964997_74965148 | 0.77 |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
62 |
0.97 |
chr21_45562472_45562665 | 0.77 |
C21orf33 |
chromosome 21 open reading frame 33 |
6567 |
0.16 |
chr10_102271059_102271210 | 0.77 |
SEC31B |
SEC31 homolog B (S. cerevisiae) |
8457 |
0.16 |
chr7_151549110_151549287 | 0.77 |
PRKAG2-AS1 |
PRKAG2 antisense RNA 1 |
24929 |
0.14 |
chr7_108167086_108167258 | 0.76 |
PNPLA8 |
patatin-like phospholipase domain containing 8 |
410 |
0.87 |
chr5_783949_784100 | 0.76 |
ZDHHC11B |
zinc finger, DHHC-type containing 11B |
16957 |
0.18 |
chr5_127873623_127873774 | 0.76 |
SLC27A6 |
solute carrier family 27 (fatty acid transporter), member 6 |
8 |
0.51 |
chr7_20434869_20435036 | 0.76 |
ENSG00000200753 |
. |
17998 |
0.23 |
chr3_187468271_187468431 | 0.76 |
BCL6 |
B-cell CLL/lymphoma 6 |
4836 |
0.25 |
chrX_39868343_39868494 | 0.76 |
BCOR |
BCL6 corepressor |
53772 |
0.17 |
chr12_67919530_67919842 | 0.76 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
122432 |
0.06 |
chr1_198611512_198611708 | 0.76 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
3318 |
0.31 |
chr7_155790240_155790577 | 0.76 |
AC021218.2 |
Uncharacterized protein |
35082 |
0.22 |
chr8_97506971_97507442 | 0.76 |
SDC2 |
syndecan 2 |
970 |
0.67 |
chr6_159107432_159107778 | 0.75 |
SYTL3 |
synaptotagmin-like 3 |
23410 |
0.17 |
chr6_108486750_108487194 | 0.75 |
OSTM1 |
osteopetrosis associated transmembrane protein 1 |
72 |
0.78 |
chr13_99702997_99703298 | 0.75 |
ENSG00000207298 |
. |
25659 |
0.17 |
chrX_153581720_153581871 | 0.75 |
FLNA |
filamin A, alpha |
258 |
0.84 |
chr11_74984720_74985495 | 0.75 |
ARRB1 |
arrestin, beta 1 |
4636 |
0.16 |
chr16_4743908_4744059 | 0.75 |
NUDT16L1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 |
221 |
0.89 |
chr4_39570957_39571108 | 0.75 |
UGDH |
UDP-glucose 6-dehydrogenase |
41101 |
0.11 |
chrX_18665752_18666019 | 0.74 |
RS1 |
retinoschisin 1 |
24344 |
0.19 |
chr20_10485213_10485441 | 0.74 |
SLX4IP |
SLX4 interacting protein |
69376 |
0.11 |
chr16_23689906_23690057 | 0.74 |
PLK1 |
polo-like kinase 1 |
162 |
0.92 |
chr4_25915196_25915424 | 0.74 |
SMIM20 |
small integral membrane protein 20 |
516 |
0.86 |
chr6_139692314_139693115 | 0.74 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
2636 |
0.37 |
chr14_101292334_101292485 | 0.74 |
AL117190.2 |
|
3128 |
0.07 |
chr10_30798424_30798582 | 0.74 |
ENSG00000239744 |
. |
46330 |
0.15 |
chr15_40763845_40764057 | 0.74 |
CHST14 |
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 |
666 |
0.52 |
chr18_72783484_72783953 | 0.73 |
ZADH2 |
zinc binding alcohol dehydrogenase domain containing 2 |
133750 |
0.05 |
chr19_3172621_3172958 | 0.73 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
5947 |
0.12 |
chr3_39426040_39426209 | 0.73 |
SLC25A38 |
solute carrier family 25, member 38 |
1244 |
0.38 |
chr1_167906843_167907071 | 0.73 |
MPC2 |
mitochondrial pyruvate carrier 2 |
679 |
0.5 |
chr2_159313027_159313178 | 0.73 |
CCDC148 |
coiled-coil domain containing 148 |
112 |
0.86 |
chr10_75533108_75533259 | 0.73 |
AC022400.2 |
Uncharacterized protein; cDNA FLJ44715 fis, clone BRACE3021430 |
805 |
0.28 |
chr9_78506329_78506658 | 0.73 |
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
872 |
0.69 |
chr4_468151_468360 | 0.72 |
ZNF721 |
zinc finger protein 721 |
299 |
0.88 |
chr16_90166281_90166438 | 0.72 |
PRDM7 |
PR domain containing 7 |
24021 |
0.14 |
chr7_130131029_130131298 | 0.72 |
MEST |
mesoderm specific transcript |
10 |
0.96 |
chr6_90528785_90528936 | 0.72 |
MDN1 |
MDN1, midasin homolog (yeast) |
577 |
0.71 |
chr12_106621904_106622084 | 0.72 |
RP11-651L5.2 |
|
18740 |
0.17 |
chr3_71491271_71491489 | 0.72 |
ENSG00000221264 |
. |
99860 |
0.07 |
chr13_108868110_108868375 | 0.72 |
LIG4 |
ligase IV, DNA, ATP-dependent |
354 |
0.87 |
chr11_60745640_60745888 | 0.72 |
CD6 |
CD6 molecule |
6426 |
0.12 |
chr5_77591328_77591479 | 0.72 |
AP3B1 |
adaptor-related protein complex 3, beta 1 subunit |
824 |
0.63 |
chr11_78130521_78130672 | 0.72 |
GAB2 |
GRB2-associated binding protein 2 |
1202 |
0.48 |
chr19_38851998_38852149 | 0.72 |
AC005625.1 |
|
1051 |
0.28 |
chr7_130596221_130596721 | 0.72 |
ENSG00000226380 |
. |
34173 |
0.19 |
chr9_136127477_136127628 | 0.72 |
OBP2B |
odorant binding protein 2B |
42922 |
0.08 |
chr1_161993174_161993534 | 0.72 |
OLFML2B |
olfactomedin-like 2B |
76 |
0.98 |
chr10_43931908_43932059 | 0.72 |
ZNF487 |
zinc finger protein 487 |
299 |
0.88 |
chr17_40761875_40762026 | 0.72 |
TUBG1 |
tubulin, gamma 1 |
246 |
0.69 |
chr1_27693189_27693396 | 0.72 |
MAP3K6 |
mitogen-activated protein kinase kinase kinase 6 |
57 |
0.96 |
chr3_136538317_136538560 | 0.72 |
SLC35G2 |
solute carrier family 35, member G2 |
512 |
0.76 |
chr10_134259846_134259997 | 0.71 |
C10orf91 |
chromosome 10 open reading frame 91 |
1228 |
0.45 |
chr14_105954302_105954472 | 0.71 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
1133 |
0.3 |
chr6_159137344_159137752 | 0.71 |
ENSG00000265558 |
. |
48237 |
0.12 |
chr2_2617541_2617908 | 0.71 |
MYT1L |
myelin transcription factor 1-like |
282758 |
0.01 |
chr3_52279387_52279538 | 0.71 |
PPM1M |
protein phosphatase, Mg2+/Mn2+ dependent, 1M |
379 |
0.72 |
chr1_108584195_108584461 | 0.71 |
ENSG00000264753 |
. |
22935 |
0.22 |
chr10_102504164_102504334 | 0.71 |
PAX2 |
paired box 2 |
1219 |
0.56 |
chr3_921603_921754 | 0.71 |
ENSG00000244169 |
. |
185881 |
0.03 |
chr8_23103726_23103920 | 0.71 |
CHMP7 |
charged multivesicular body protein 7 |
334 |
0.83 |
chr14_105952805_105952984 | 0.71 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
240 |
0.86 |
chr22_19164364_19164515 | 0.71 |
SLC25A1 |
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
1595 |
0.26 |
chr8_123794514_123794665 | 0.71 |
ZHX2 |
zinc fingers and homeoboxes 2 |
956 |
0.61 |
chr10_118935479_118935630 | 0.70 |
ENSG00000266782 |
. |
8269 |
0.17 |
chr8_10696646_10696877 | 0.70 |
PINX1 |
PIN2/TERF1 interacting, telomerase inhibitor 1 |
520 |
0.45 |
chr3_189111420_189111804 | 0.70 |
TPRG1-AS2 |
TPRG1 antisense RNA 2 |
153229 |
0.04 |
chr1_51436416_51436897 | 0.70 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
1040 |
0.56 |
chr9_137533869_137534020 | 0.70 |
COL5A1 |
collagen, type V, alpha 1 |
324 |
0.9 |
chr5_76926843_76927107 | 0.70 |
OTP |
orthopedia homeobox |
8538 |
0.23 |
chrX_62965690_62965845 | 0.70 |
ARHGEF9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
9221 |
0.25 |
chr10_98272583_98272734 | 0.70 |
TLL2 |
tolloid-like 2 |
1010 |
0.62 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.5 | 1.5 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.5 | 1.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.4 | 1.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 1.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 1.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.4 | 0.7 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.4 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 1.0 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 2.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.6 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.3 | 0.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.3 | 1.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.3 | 1.7 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.3 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 0.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 0.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.3 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 1.6 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.3 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.8 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 1.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 0.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.2 | 0.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 1.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.7 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.2 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 1.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 1.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.6 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.2 | 0.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.6 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 1.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.2 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 2.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 1.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.8 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.2 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.8 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.6 | GO:0003417 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.2 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 1.7 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 0.5 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.5 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.2 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.2 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 0.5 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.3 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.2 | 0.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.5 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 1.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 0.3 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.2 | 1.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 0.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.8 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.2 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.2 | 0.5 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.2 | 1.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.5 | GO:1902019 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.8 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.2 | 0.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.6 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.8 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 1.4 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.1 | GO:2000696 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.9 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.6 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.4 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.3 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.7 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.4 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 1.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.4 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 1.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 1.1 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.1 | GO:0014808 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.1 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.1 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.3 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.1 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 1.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.5 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 2.0 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.6 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.6 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.4 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.6 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.2 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.2 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.8 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 0.1 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.1 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.1 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.1 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.6 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.9 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 0.6 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 1.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.3 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 1.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.2 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.7 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.4 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.2 | GO:0071514 | regulation of gene expression by genetic imprinting(GO:0006349) genetic imprinting(GO:0071514) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.2 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 1.4 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.7 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 1.5 | GO:0035338 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0070875 | positive regulation of glucose metabolic process(GO:0010907) positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 1.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 1.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 2.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.3 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.1 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.4 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 1.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.4 | GO:0072422 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.6 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.6 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.1 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.1 | 0.1 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.5 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.2 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.8 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.4 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.1 | 0.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 1.1 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 0.5 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.2 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.1 | 4.3 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 2.1 | GO:0051318 | G1 phase(GO:0051318) |
0.1 | 0.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 1.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.2 | GO:0003099 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.2 | GO:0014044 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.5 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.4 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 0.2 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.3 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.4 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.1 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.1 | 0.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.5 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.1 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 1.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.4 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 1.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.1 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.6 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 1.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.2 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.4 | GO:0043954 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.1 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.6 | GO:0071377 | response to glucagon(GO:0033762) cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.2 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.1 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.5 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 1.3 | GO:0061641 | DNA replication-independent nucleosome assembly(GO:0006336) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.5 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.2 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.1 | 0.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 4.6 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.1 | GO:0042991 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.1 | 0.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.2 | GO:0060479 | lung cell differentiation(GO:0060479) |
0.1 | 0.6 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 1.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.1 | 0.3 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 1.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 1.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.1 | GO:0035112 | embryonic genitalia morphogenesis(GO:0030538) genitalia morphogenesis(GO:0035112) |
0.1 | 0.3 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.1 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.2 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.1 | 0.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 1.7 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.2 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.6 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.1 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 1.0 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 1.2 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.4 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.3 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 1.5 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 0.2 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.1 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.1 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.0 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.1 | GO:0061387 | regulation of axon extension(GO:0030516) regulation of extent of cell growth(GO:0061387) |
0.1 | 1.0 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.7 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.2 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.2 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.6 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 1.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 6.3 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0022406 | membrane docking(GO:0022406) |
0.1 | 0.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.1 | GO:0033233 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.2 | GO:0035850 | epithelial cell differentiation involved in kidney development(GO:0035850) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.9 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.3 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.1 | 0.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.1 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.1 | 0.1 | GO:0002864 | regulation of acute inflammatory response to antigenic stimulus(GO:0002864) |
0.1 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 0.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 1.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 5.9 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.5 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.9 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 4.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.0 | 0.4 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.2 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.0 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 1.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.0 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.3 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 1.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.1 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0060350 | endochondral bone morphogenesis(GO:0060350) |
0.0 | 0.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.0 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.0 | 0.1 | GO:0045429 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of reactive oxygen species biosynthetic process(GO:1903428) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.0 | 0.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0051153 | regulation of striated muscle cell differentiation(GO:0051153) |
0.0 | 1.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 1.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.0 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.9 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.0 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.1 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 1.2 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.3 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0071331 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.3 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 1.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 1.9 | GO:0044839 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.0 | 0.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.0 | GO:2000142 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) regulation of DNA-templated transcription, initiation(GO:2000142) |
0.0 | 0.1 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.4 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 1.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.4 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.3 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.4 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.4 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.0 | 0.7 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.6 | GO:0070997 | neuron death(GO:0070997) |
0.0 | 0.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.3 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
0.0 | 0.5 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 1.0 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.1 | GO:0048708 | astrocyte differentiation(GO:0048708) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 1.5 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 1.7 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 3.4 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.1 | GO:0042816 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 1.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 2.9 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 2.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 1.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 4.7 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.4 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.0 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.0 | 0.4 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.1 | GO:0006323 | DNA packaging(GO:0006323) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.2 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.0 | 0.4 | GO:0072378 | blood coagulation, intrinsic pathway(GO:0007597) blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 7.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 3.1 | GO:0016032 | viral process(GO:0016032) |
0.0 | 0.0 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.0 | 0.2 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.8 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0010819 | T cell chemotaxis(GO:0010818) regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) T cell migration(GO:0072678) regulation of lymphocyte chemotaxis(GO:1901623) regulation of lymphocyte migration(GO:2000401) positive regulation of lymphocyte migration(GO:2000403) regulation of T cell migration(GO:2000404) positive regulation of T cell migration(GO:2000406) |
0.0 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.6 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 1.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 1.5 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 2.3 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.0 | 0.5 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 0.1 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.0 | 0.1 | GO:0006325 | chromatin organization(GO:0006325) |
0.0 | 0.2 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.2 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.1 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.0 | GO:0072189 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter development(GO:0072189) |
0.0 | 0.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.1 | GO:1901992 | positive regulation of cell cycle phase transition(GO:1901989) positive regulation of mitotic cell cycle phase transition(GO:1901992) |
0.0 | 0.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.3 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 3.0 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.1 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.2 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.2 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.3 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.0 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 2.1 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.0 | GO:0007098 | centrosome cycle(GO:0007098) |
0.0 | 0.1 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.4 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.0 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.3 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.6 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0009304 | tRNA transcription(GO:0009304) |
0.0 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 1.6 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.0 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.0 | 0.2 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.9 | GO:0045333 | cellular respiration(GO:0045333) |
0.0 | 0.6 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 1.0 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.0 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.0 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.9 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.1 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.5 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0043491 | protein kinase B signaling(GO:0043491) |
0.0 | 0.1 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.0 | 0.0 | GO:0022618 | ribonucleoprotein complex assembly(GO:0022618) |
0.0 | 0.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.5 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 0.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.0 | GO:0050433 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) regulation of catecholamine secretion(GO:0050433) |
0.0 | 0.0 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0015810 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.0 | 0.0 | GO:0060491 | regulation of cell projection assembly(GO:0060491) |
0.0 | 0.0 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 5.2 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.3 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0032200 | telomere organization(GO:0032200) |
0.0 | 0.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0006528 | asparagine metabolic process(GO:0006528) asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.1 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.3 | GO:0015758 | hexose transport(GO:0008645) glucose transport(GO:0015758) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.1 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.0 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.0 | 0.2 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.0 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.6 | GO:0001558 | regulation of cell growth(GO:0001558) |
0.0 | 0.0 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.0 | 0.5 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.0 | GO:0055069 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.0 | 0.0 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.0 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.0 | GO:0045117 | azole transport(GO:0045117) |
0.0 | 0.0 | GO:0032438 | melanosome organization(GO:0032438) |
0.0 | 0.0 | GO:0048660 | regulation of smooth muscle cell proliferation(GO:0048660) |
0.0 | 0.0 | GO:0044042 | cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.1 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.0 | 0.0 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway(GO:0002768) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 1.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.6 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.2 | 1.4 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.5 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.1 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 2.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.6 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.7 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 1.1 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.8 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 1.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.2 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 0.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 1.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.3 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.1 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 3.7 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 6.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 1.7 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.3 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.4 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 1.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 2.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 2.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 3.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.9 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.3 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 3.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 3.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 1.0 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 7.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.1 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 3.5 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.8 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 11.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 4.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 1.2 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 10.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 2.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.6 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 4.8 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 2.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.0 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 1.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 1.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.4 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 2.9 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 1.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 1.3 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 3.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 2.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 4.6 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.9 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.0 | 0.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 2.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 2.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.5 | GO:0030496 | midbody(GO:0030496) |
0.0 | 29.3 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 27.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 1.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.1 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 1.4 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 7.3 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.8 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0036464 | ribonucleoprotein granule(GO:0035770) cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.7 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.6 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 25.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 1.3 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 0.4 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 84.5 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.4 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.4 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.4 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 5.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 1.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 16.3 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 1.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0045202 | synapse(GO:0045202) |
0.0 | 4.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 23.5 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 1.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.2 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.0 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 38.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 8.1 | GO:0044464 | cell part(GO:0044464) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 0.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.3 | 0.8 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.3 | 1.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.7 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 3.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 1.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.8 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 2.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 0.6 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 1.7 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 2.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 3.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 3.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.5 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 1.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.6 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 1.0 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.6 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 1.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 1.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 2.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.3 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 1.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 3.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 6.6 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 4.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.4 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.3 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 3.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 2.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 1.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.9 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.1 | 0.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 4.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 3.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.5 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 6.2 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 2.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.2 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 1.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.2 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 1.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 1.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 9.5 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.6 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.5 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 1.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.5 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.7 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 1.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 5.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.4 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 1.3 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.0 | 0.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 2.1 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 1.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 1.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 1.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 1.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 2.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.7 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 9.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.3 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.9 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.6 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 51.7 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 1.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.4 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.0 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 2.1 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.1 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 1.2 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 8.7 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.1 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.3 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 1.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 1.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 4.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.4 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 2.0 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.8 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.5 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 3.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 1.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 4.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 2.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.4 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) dioxygenase activity(GO:0051213) |
0.0 | 1.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 2.0 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.0 | 0.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 4.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 1.1 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.6 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.5 | GO:0050662 | coenzyme binding(GO:0050662) |
0.0 | 0.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.9 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 4.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.5 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 3.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 3.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 4.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 3.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.5 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 5.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.3 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 2.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 2.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 4.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 2.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 6.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 2.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 3.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 6.0 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.1 | 1.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 2.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 1.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 4.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.5 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 1.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 2.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 3.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 15.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 4.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 2.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 5.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 2.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 2.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.3 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 2.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 1.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 4.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 2.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 1.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.8 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.0 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |